GenNxeix Inc Houston Office is location at
The Houston Technology Center
410 Pierce Street Houston, TX 77002-4313
in DownTown Houston. A Second office is opening in June in the Williams Tower in the Houston Galleria in June.
"After an extensive and thorough search, we're delighted to have selected Flores as our new CEO," said GenNxeix company founder and board chairman Robert Graham Ph.D.
"Flores is a terrific product executive who has also demonstrated exceptional business and leadership skills. She's a perfect fit to take GenNxeix into the future. We will leverage Flores' extensive background in customer-driven product strategy and delivery to ensure GenNxeix' strategic plan is focused and optimized for growth.""Honored to be joining GenNxeix, an industry pioneer in Genomic science applications and services," Flores said. "While there's a lot of work to do, GenNxeix has incredible and unique assets upon which to build, including a very talented team. I'm excited about the opportunity to help lead GenNxeix on to the next great chapter in its success. "
Flores will be taking over from Rose Conrad, who has served as CEO since March 1999. Conrad, who has been an executive at GenNxeix since 1998,
GenNxeix creates innovative Genomic Biotech applications and services that make it easy for Cancer Patients to make intelligent decesions about chemotherapy. GenNxeix invented the GenNxeix Breast Cancer Toolkit aiming to support every Breast Cancer Patient, Clinical Trial, and Doctors Office Find corporate information at HYPERLINK "http://www.GenNxeix.com" www.GenNxeix.com/
GenNxeix is a registered trademark of GenNxeix, Inc. All other trademarks, names of actual companies and products mentioned herein are the property of their respective owners.
Forward Looking Statements: This press release contains forward-looking statements that involve risks and uncertainties, including statements relating to the future success of GenNxeix. More information about potential risk factors that could affect business and financial results is included in the GenNxeix annual report on Form 10-K for the most recent year ended December 31, and its quarterly reports on Form 10-Q and, from time to time, in other reports filed by GenNxeix. Actual results may differ materially from estimates under different assumptions or conditions. GenNxeix assumes no obligation to update any forward-looking statements or information, which are in effect as of their respective dates.
SOURCE GenNxeix, Inc.
Houston, Feb. 08, 2012 /PRNewswire/ -- GenNxeix, Inc. Today announced that its board of directors has named Selene Flores as its new president and Chief Executive Officer. Selene, who will also become a member of its Board of Directors, starts at GenNxeix on January 24th.
GenNxeix Inc Houston is location at
The Houston Technology Center
410 Pierce Street Houston, TX 77002-4313
in DownTown Houston. A Second office is opening in June in the Williams Tower in the Houston Galleria in June.
"After an extensive and thorough search, we're delighted to have selected Flores as our new CEO," said GenNxeix company founder and board chairman Robert Graham Ph.D.
HYPERLINK "https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjb7_1W5KcJ2p2B9ydsYy-pLH38Ts3pN-RDZCXLlsNyXxKA5POcG8Z4IiiuY5mgiZQBapakWynWJtuj2QwjX1oly_QejYH2AHGe1k7pNZZ23BwzOj2WuEvSYGcot0SQzBcffpeRNTMWziLP/s1600/2012-01-24+14.49.28.jpg" SHAPE \* MERGEFORMAT
"Flores is a terrific product executive who has also demonstrated exceptional business and leadership skills. She's a perfect fit to take GenNxeix into the future. We will leverage Flores' extensive background in customer-driven product strategy and delivery to ensure GenNxeix' strategic plan is focused and optimized for growth."
"Honored to be joining GenNxeix, an industry pioneer in Genomic science applications and services," Flores said. "While there's a lot of work to do, GenNxeix has incredible and unique assets upon which to build, including a very talented team. I'm excited about the opportunity to help lead GenNxeix on to the next great chapter in its success. "
Flores will be taking over from Rose Conrad, who has served as CEO since March 1999. Conrad, who has been an executive at GenNxeix since 1998,
GenNxeix creates innovative Genomic Biotech applications and services that make it easy for Cancer Patients to make intelligent decesions about chemotherapy. GenNxeix invented the GenNxeix Breast Cancer Toolkit aiming to support every Breast Cancer Patient, Clinical Trial, and Doctors Office Find corporate information at HYPERLINK "http://www.GenNxeix.com" www.GenNxeix.com/
GenNxeix is a registered trademark of GenNxeix, Inc. All other trademarks, names of actual companies and products mentioned herein are the property of their respective owners.
Forward Looking Statements: This press release contains forward-looking statements that involve risks and uncertainties, including statements relating to the future success of GenNxeix. More information about potential risk factors that could affect business and financial results is included in the GenNxeix annual report on Form 10-K for the most recent year ended December 31, and its quarterly reports on Form 10-Q and, from time to time, in other reports filed by GenNxeix. Actual results may differ materially from estimates under different assumptions or conditions. GenNxeix assumes no obligation to update any forward-looking statements or information, which are in effect as of their respective dates.
SOURCE GenNxeix, Inc.
No comments:
Post a Comment